期刊
JOURNAL OF ORGANIC CHEMISTRY
卷 83, 期 13, 页码 6924-6935出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.7b02318
关键词
-
资金
- Takeda Science Foundation
- JSPS
- Tokyo Biochemical Research Foundation
- [JP17H06110]
- [JP16H01130]
- [JP17K15421]
- [JP15H05783]
- Grants-in-Aid for Scientific Research [17H06110, 16J08733] Funding Source: KAKEN
WAP-8294A2 (lotilibcin, 1) is a potent antibiotic with superior in vivo efficacy to vancomycin against methicillin-resistant Staphylococcus aureus (MRSA). Despite the great medical importance, its molecular mode of action remains unknown. Here we report the total synthesis of complex macrocyclic peptide 1 comprised of 12 amino acids with a beta-hydroxy fatty-acid chain, and its deoxy analogue 2. A full solid-phase synthesis of 1 and 2 enabled their rapid assembly and the first detailed investigation of their functions. Compounds 1 and 2 were equipotent against various strains of Gram-positive bacteria including MRSA. We present evidence that the antimicrobial activities of 1 and 2 are due to lysis of the bacterial membrane, and their membrane disrupting effects depend on the presence of menaquinone, an essential factor for the bacterial respiratory chain. The established synthetic routes and the menaquinone-targeting mechanisms provide valuable information for designing and developing new antibiotics based on their structures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据